Portugal pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 7 of 25 of this archive, newest first.
The evidence base is thin and the document says so, which is to its credit.
What was pre-specified, what was exploratory, and what was calculated afterwards by people who did not run the trial.
The evidence base is thin and the document says so, which is to its credit.
Mass and function are different endpoints and training affects them differently. Most coverage treats them as one.
The evidence base is thin and the document says so, which is to its credit.
The receptor populations that produce satiety and the ones that produce nausea overlap substantially. That is why the ceiling of this drug class is where it is, and it is…
Every withdrawal trial compared full dose against nothing. The clinically interesting comparison — full dose against a reduced one — has not been randomised.
Reduced intake is a plausible mechanism for deficiency. Reduced absorption is not, and the two are conflated in most of the advice.
The evidence base is thin and the document says so, which is to its credit.
The evidence base is thin and the document says so, which is to its credit.
The evidence base is thin and the document says so, which is to its credit.
The evidence base is thin and the document says so, which is to its credit.
A substudy powered to describe a mean is not a substudy powered to detect a clinically meaningful individual change.
The evidence base is thin and the document says so, which is to its credit.
The evidence base is thin and the document says so, which is to its credit.
The evidence base is thin and the document says so, which is to its credit.
The air shot before a pen injection removes air from the cartridge and confirms flow. Skipping it can mean a materially reduced dose, and it is skipped constantly.
The evidence base is thin and the document says so, which is to its credit.
Dose reduction is not withdrawal, and the trials that tested withdrawal cannot be read as testing it.
Higher doses of these molecules have been studied. In general they produced modest additional efficacy and disproportionate additional symptom burden, which is why the…